Cart summary

You have no items in your shopping cart.

Saroglitazar Magnesium

SKU: orb1708589

Description

Saroglitazar Magnesium is a dual PPARα/γ agonist, exhibiting potent PPARα activation (EC50 0.65 pM) and moderate PPARγ activation (EC50 3 nM). This investigational compound is utilized in preclinical research for studying metabolic disorders, including dyslipidemia and fatty liver disease, in both cellular and animal models.

Research Area

Metabolism Research, Molecular Biology

Images & Validation

Key Properties

CAS Number1639792-20-3
MW901.43
Purity99.40% (May vary between batches)
FormulaC50H56MgN2O8S2
SMILESC(C)O1[Mg+2]2(O(CC)C(CC3=CC=C(OCCN4C(=CC=C4C)C5=CC=C(SC)C=C5)C=C3)C(=O)[O-]2)[O-]C(=O)C1CC6=CC=C(OCCN7C(=CC=C7C)C8=CC=C(SC)C=C8)C=C6
TargetOthers,PPAR
SolubilityDMSO:112.5 mg/mL (124.8 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (4.44 mM)

Bioactivity

Target IC50
PPARγ:3 nM (EC50, HepG2 cell)|PPARα:0.65 pM (EC50, HepG2 cell)
In Vivo
In db/db mice, Saroglitazar (0.01-3 mg/kg per day, orally) treatment with 12-day causes dose-dependent reductions in serum triglycerides (TG), free fatty acids (FFA), and glucose. The ED50 for these effects is found to be 0.05, 0.19, and 0.19 mg/kg, respectively with highly significant (91%) reduction in serum insulin and AUC-glucose following oral glucose administration (59%) at 1 mg/kg dose.in Wistar rats and marmosets A 90-day repeated dose comparative study confirms efficacy (TG lowering) potential of Saroglitazar and has indicated low risk of PPAR-associated side effects in humans. Based on efficacy and safety profile, Saroglitazar appears to have good potential as novel therapeutic agent for treatment of dyslipidemia and diabetes.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

PPARγ, PPARα, Saroglitazar Magnesium
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Saroglitazar Magnesium (orb1708589)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
¥ 1,300.00
5 mg
¥ 2,340.00
1 ml x 10 mM (in DMSO)
¥ 3,380.00
10 mg
¥ 3,380.00
25 mg
¥ 5,070.00
50 mg
¥ 6,630.00
100 mg
¥ 8,320.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry